CytoDyn Selects Capital Growth Resources.

SANTA FE, N.M. -- CytoDyn, Inc. (Pink Sheets:CYDY) has entered into a Letter of Intent with Capital Growth Resources (CGR). Under the letter of intent, CGR will advise the company regarding future financing and has agreed to act as the Company's new placement agent for a planned offering of the Company's securities.

About CytoDyn

CytoDyn, Inc. is a Colorado corporation with its home office in Santa Fe, NM. The Company makes quarterly and annual reports to the SEC and states that its mission is "to develop first-in-class drugs for treating and for preventing serious human diseases."

Please visit our web site at www.cytodyn.com for more information.

About Capital Growth Resources

CGR was founded in 1980 as a Broker-Dealer registered with the National Association of Securities Dealers (NASD) and the Securities & Exchange Commission (SEC). CGR transacts a full range of investment products, including the purchasing, selling, and exchanging of public and private securities. CGR also works with several investment banking firms who represent venture capitalist, hedge funds and institutional investors specializing in the raising of capital for private and public companies.

Disclaimer

This press release does not constitute an offer to sell nor is it a solicitation of an offer in any of the Company's securities. This press release contains forward-looking statements that are not historical facts. The Company's management makes forward-looking statements concerning the Company's expected future operations, performance and other developments. These forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. There can be no assurance that such risks and uncertainties, or other factors, will not affect the accuracy of such forward-looking statements. It is impossible to identify all factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, victimization by white-collar offenders, and the effects of adverse publicity, litigation, competition, and other factors that may be identified from time to time in the Company's announcements.